Equities

Allovir Inc

ALVR:NAQ

Allovir Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)0.57
  • Today's Change0.000 / -0.02%
  • Shares traded322.44k
  • 1 Year change-63.46%
  • Beta0.6434
Data delayed at least 15 minutes, as of Nov 21 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Key statistics

On Thursday, Allovir Inc (ALVR:NAQ) closed at 0.57, 10.62% above the 52 week low of 0.5153 set on Nov 19, 2024.
52-week range
Today
0.5153Nov 19 20242.49Dec 14 2023
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open0.57
High0.591
Low0.5461
Bid0.55
Offer0.6599
Previous close0.5701
Average volume646.42k
Shares outstanding115.54m
Free float58.79m
P/E (TTM)--
Market cap65.86m USD
EPS (TTM)-0.8755
USD
Data delayed at least 15 minutes, as of Nov 21 2024 21:00 GMT.
More ▼

Events & Activity

  • ALVR:NAQ price reached a new 52-week low of 0.530 at 09:41 GMT
  • ALVR:NAQ price moved over +3.53% to 0.5891
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.